Genestra Brands Mobility Joint + NEM
Natural health product licensed in Canada
- Other names
- Genestra Brands Mobility + Joint Care, Genestra Brands Mobility Joint +, Genestra Brands Mobility Joint + (with NEM), Genestra Brands MobilityPlus Rapid Relief, Genestra Brands MobilityPlus Rapid Relief (with NEM), Genestra Brands MobilityPlus Rapid Relief (with NEM, Boswellia & Bromelain)
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80118636
- Status
- Active licence
- Licence date
- 13 May 2022
- Revision date
- 1 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 25 mg | 75,000 µg |
| Vitamine C Source : Palmitate d'ascorbyle | 25 mg | 75,000 µg |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 720,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 20 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Used in herbal medicine to help relieve minor pain, swelling and inflammation. A factor in the maintenance of good health. Antioxidant for good health. Contributes to maintaining general health. For maintaining general health. Helps (to) maintain/support immune function. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps with immune function. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Supports good health. Vitamin supplement. Source of vitamin, a factor/factors in the maintenance of good health. Source of vitamin to support biological functions which play a key role in the maintenance of good health. (NEM) helps reduce joint stiffness associated with osteoarthritis. (NEM) helps reduce joint pain and stiffness. (NEM) clinically proven to reduce joint pain in 7 to 10 days. . (NEM) increases joint flexibility. (NEM) helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). (NEM) helps to relieve pain associated with osteoarthritis (of the knee and/or hip). (NEM®) helps to minimize discomfort due to moderate intensity aerobic exercise (in postmenopausal women). (NEM®) helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise (in post-menopausal women). (NEM®) helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise (in post-menopausal women). (NEM®) helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise (in post-menopausal women). (NEM®) helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). (NEM®) starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. (NEM®) is clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118636
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging